# Arsenic Nanoparticles Trigger Apoptosis via Anoikis Induction in OECM-1 Cells

**Authors:** Alejandra A. Covarrubias, Mauricio Reyna-Jeldes, Seidy Pedroso-Santana, Sabrina Marín, Carolina Madero-Mendoza, Cecilia Demergasso, Claudio Coddou

PMC · DOI: 10.3390/ijms25126723 · 2024-06-18

## TL;DR

Arsenic nanoparticles from a Chilean bacterium induce apoptosis in oral cancer cells by triggering anoikis, a type of cell death linked to loss of cell attachment.

## Contribution

The study reveals a novel mechanism by which arsenic nanoparticles induce apoptosis via anoikis in cancer cells.

## Key findings

- AsNPs reduced OECM-1 cell viability in a concentration-dependent manner.
- AsNPs induced both extrinsic and intrinsic apoptotic pathways in OECM-1 cells.
- AsNPs triggered anoikis by potentially interacting with ECM components and reducing cell attachment.

## Abstract

Arsenic compounds have been used as therapeutic alternatives for several diseases including cancer. In the following work, we obtained arsenic nanoparticles (AsNPs) produced by an anaerobic bacterium from the Salar de Ascotán, in northern Chile, and evaluated their effects on the human oral squamous carcinoma cell line OECM-1. Resazurin reduction assays were carried out on these cells using 1–100 µM of AsNPs, finding a concentration-dependent reduction in cell viability that was not observed for the non-tumoral gastric mucosa-derived cell line GES-1. To establish if these effects were associated with apoptosis induction, markers like Bcl2, Bax, and cleaved caspase 3 were analyzed via Western blot, executor caspases 3/7 via luminometry, and DNA fragmentation was analyzed by TUNEL assay, using 100 µM cisplatin as a positive control. OECM-1 cells treated with AsNPs showed an induction of both extrinsic and intrinsic apoptotic pathways, which can be explained by a significant decrease in P-Akt/Akt and P-ERK/ERK relative protein ratios, and an increase in both PTEN and p53 mRNA levels and Bit-1 relative protein levels. These results suggest a prospective mechanism of action for AsNPs that involves a potential interaction with extracellular matrix (ECM) components that reduces cell attachment and subsequently triggers anoikis, an anchorage-dependent type of apoptosis.

## Linked entities

- **Genes:** BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], PTEN (phosphatase and tensin homolog) [NCBI Gene 5728], TP53 (tumor protein p53) [NCBI Gene 7157], PTRH2 (peptidyl-tRNA hydrolase 2) [NCBI Gene 51651]
- **Proteins:** BCL2 (BCL2 apoptosis regulator), BAX (BCL2 associated X, apoptosis regulator), Akt (Akt kinase), AKT1 (AKT serine/threonine kinase 1), EIF2AK3 (eukaryotic translation initiation factor 2 alpha kinase 3), EPHB2 (EPH receptor B2), PTRH2 (peptidyl-tRNA hydrolase 2)
- **Chemicals:** cisplatin (PubChem CID 5460033)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, PTRH2 (peptidyl-tRNA hydrolase 2) [NCBI Gene 51651] {aka BIT1, CFAP37, CGI-147, IMNEPD, PTH 2, PTH2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}
- **Diseases:** oral squamous carcinoma (MESH:D000077195), cancer (MESH:D009369)
- **Chemicals:** cisplatin (MESH:D002945), Arsenic Nanoparticles (-), Arsenic (MESH:D001151), Resazurin (MESH:C005843)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** GES-1 — Homo sapiens (Human), Transformed cell line (CVCL_EQ22), OECM-1 — Homo sapiens (Human), Gingival squamous cell carcinoma, Cancer cell line (CVCL_6782)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11204275/full.md

---
Source: https://tomesphere.com/paper/PMC11204275